the Fetal Epicardial Thickness in Obese Pregnant Women (EFT)

The Effect of Myocardial Performance Index and Fetal Epicardial Thickness on Perinatal Outcomes in Obese Pregnant Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05948319

Acronym

EFT

Enrollment

120

Registered

2023-07-17

Start date

2022-10-01

Completion date

2023-04-30

Last updated

2023-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetus Fetus, Pregnancy Complications

Keywords

obesity,, fetal epicardial thickness, myocardial performance index, perinatal outcome

Brief summary

the effects of fetal EFT on fetal cardiac function and fetal and maternal outcomes were investigated in obese pregnant women compared with normal-weight pregnant women.

Detailed description

All pregnant women underwent a comprehensive fetal anomaly screening. One obstetrician (S.D.) assessed all of the measurements. Every measurement was performed using a convex 2-5 MHz Voluson E8 probe (GE Healthcare, Milwaukee, WI). Fetal biometry, UA, MCA Doppler, cerebroplacental ratio (CPR), modified MPI (mod-MPI), and EFT were assessed in accordance with the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidelines

Interventions

DIAGNOSTIC_TESTDoppler ultrasonography

Doppler study was performed in all cases. perinatal outcomes were evaluated.

Study design

Allocation

NON_RANDOMIZED

Intervention model

SEQUENTIAL

Primary purpose

SCREENING

Masking

SINGLE (Subject)

Masking description

obese and non obese pregnant women

Intervention model description

case control

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Obese pregnant women * normal-weight pregnant women * 24-40 gestational week

Exclusion criteria

Twin pregnancies, structural and chromosomal abnormalities, fetal rhesus isoimmunization, fetal growth restriction, cases with infections detected by maternal serological tests, pregestational or gestational diabetes (All patients underwent a 75-gram glucose load test at 24 weeks to rule out diabetes), preeclampsia, premature rupture of membranes were excluded from the study -

Design outcomes

Primary

Measure	Time frame	Description
birth weight (gram)	birth 1 week	fetal outcome
stillbirth rate (%)	birth 1 week	fetal outcome
NICU admission	6 months	fetal outcome

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026